SLPMA President Dinesh Athapaththu says pharmaceutical manufacturing can become one of next star industriesInsists on building global competitiveness by leveraging Sri Lanka’s scientific talent and proximity to IndiaOutlines five pillars for industry transformationThe Sri Lanka Pharmaceutical Manufacturers’
News & Events
- Home
- News & Events
Seeks policy reset to unlock export potentialSector aims to transition from import substitution to a lucrative export hub by leveraging Sri Lanka’s untapped pool of science graduates Manufacturers urge the immediate removal of crippling product development taxes and
Sri Lanka pharmaceutical manufacturers have the potential to tap the global pharmaceutical industry worth USD 1.8 trillion, Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA) President Dinesh Athapaththu told the 60th SLPMA Annual General Meeting (AGM) held in Colombo
Sri Lanka can be a hub for pharmaceutical manufacturing in the region, if it could improve on quality and delivery of products, said a pharmaceutical industry expert and consultant last week.“Sri Lanka’s pharmaceutical industry has the potential
* Lift VAT on imported packaging material * Local manufacturing will grow sharply slashing forex outflow Sri Lanka’s pharmaceutical industry is dominated by imported products meeting over 80% of market demand while local manufacturers are struggling to
From left: Yaden Laboratories Chief Executive Officer Prakash Babu, Chairman/Managing Director Shashimal Dissanayake, Katunayake Export Processing Zone Director A.S.K.T. Ranjan Sibera, and Snr. Deputy Director – Environment Management Nandana Karunarathna Yaden Laboratories Ltd., has achieved a significant milestone
The Sri Lanka Pharmaceutical Manufacturers' Association extends its heartfelt congratulations to Immediate Past President, Mr. Kalana Gamini Hewamallika, Chairman of GammaInterpharm (Pvt) Ltd.He has achieved a remarkable milestone by receiving the prestigious Platinum Award for "Sri Lankan
The Sri Lanka Pharmaceutical Manufacturers Association (SLPMA) issued a call to action urging all stakeholders within the local pharmaceutical industry to shape a future where Sri Lanka emerges as a trusted, high-quality, and export-driven pharmaceutical manufacturing hub.The
The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA), in a historic step, issued a powerful national call to action urging all stakeholders to come together in a bold, unified effort to shape a future where Sri Lanka emerges